Trial
NCT05866679
Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging
Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
M.D. Anderson Cancer Center
Collaborators
—
Condition
Ovarian Cancer
Intervention
Hyperpolarized 13-C-pyruvate
Why stopped
Suspension
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-15